Head of BatesCarey's Opioid Coverage Task Force Adam Fleischer was featured in the February 2018 issue of CLM Magazine's Between The Lines Q&A in which various industry leaders weighed in on how opioid litigation will evolve in the coming year.

In light of a few recent large verdicts in the Chicago area, insurers need to understand potential impacts and the importance of having the legal tool of remittitur at the ready, according to Agelo L. Reppas in her recent Law360 analysis.

With a federal judge revealing his determination to resolve opioid claims without briefs or trials, and with journalistic investigations blowing open the distributors’ culpability, there may be a massive opioid settlement looming in 2018, according to Adam Fleischer and Kevin Harris of BatesCarey’s Opioid Coverage Task Force.

Jason P. Minkin and Brian J. Watson have published a Wrongful Birth Survey of Reported Verdicts and Settlements in DRI’s The Voice (Volume 16 Issue 43).  The Survey addresses verdicts and settlements reported in wrongful birth cases across the country, spanning the last 15 years, in order to better understand the potential exposure presented by wrongful birth claims.  A full...

Adam Fleischer and Kevin Harris of BatesCarey’s Opioid Coverage Task Force published an article on Law360.com discussing the significance of the Judicial Panel on Multidistrict Litigation’s possible consolidation of opioid litigation pending nationally into a single multidistrict litigation or “MDL”. This byline was the 8th most-read article across all of Law360’s coverage in 2017.

Jason P. Minkin and Amanda E. Bushemi published an article in DRI’s The Critical Path Construction Law Newsletter entitled Recent Developments in Architects and Engineers Claims.  This article discusses several recent noteworthy decisions from courts across the U.S. examining liability and insurance coverage issues that impact architects and engineers.

R.Patrick Bedell and Kevin F. Harris of BatesCarey’s Opioid Coverage Task Force published an article on Law360.com discussing the significance of the California Court of Appeals’ ruling that insurers of Actavis, Inc., a manufacturer of prescription opioids, had no duty to defend lawsuits alleging that Actavis fraudulently misrepresented the dangers of prescription opioids and...

Jason P. Minkin and Jonathan A. Cipriani have published an article in The Maritime Advocate entitled Direct Actions Against Insurers and U.S. Limitation of Liability. The article examine a recent US court case addressing the interplay between the Louisiana Direct Action Statute and the U.S. Shipowner’s Limitation of Liability Act.

In this article by Adam H. Fleischer, the Chairperson of BatesCarey’s Opioid Coverage Task Force, we examine recent developments that have broadened the liabilities of pharmaceutical companies for the manufacture and distribution of prescription opioids and new questions as to whether opioid liability can be covered by insurance.

BatesCarey LLP is excited to announce that on Tuesday, October 17, Patrick Bedell and Kevin Harris, members of the country’s first-ever Opioid Coverage Task Force, will be teaming up with plaintiff’s attorney Marie Napoli and Perrin Conferences to host a webinar discussing the wave of opioid litigation pending against pharmaceutical companies nationwide and the insurance...